Project Grant R41DK131650

Award Date 9/1/21
Completion Date 8/31/23
Dollars Obligated $770K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Laurel, MD, USA
Similar Awards
This Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,189,332 to Sentire Medical Systems, Inc. to develop an intraoperative monitoring device to detect bowel injuries during laparoscopic surgical procedures. The project aims to create a gas-based sensing system that can identify specific gas compounds that escape into the abdominal cavity upon a bowel injury, enabling earlier detection of...
Sentire Medical Systems, Inc. was awarded a $256,000 National Science Foundation Project Grant to develop an intraoperative monitoring device to detect bowel injuries during laparoscopic surgical procedures. The goal of the NSF Technology, Innovation, and Partnerships program is to advance science and engineering research leading to breakthrough technologies that address national challenges. Through this award, Sentire Medical will characterize gases present during laparoscopic surgery to...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) provides $838,162 to Averto Medical Inc. to conduct a clinical trial of the Coloseal ICD System, a novel medical device designed to eliminate the need for temporary ostomy surgeries in rectal cancer patients. The Coloseal ICD System is a minimally-invasive technology that can safely replace the function of temporary ostomies, which are commonly required for rectal cancer...
This Project Grant awarded by the National Cancer Institute (NCI), under the federal Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,789 to Ergami Endoscopy, Inc. to develop an automated robotic flexible overtube device capable of blind insertion during colonoscopy procedures. The device aims to reduce physician injuries, improve productivity, and decrease patient pain/sedation requirements for the over 16 million colonoscopies performed annually in the U.S. Key...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) provides $306,735 to support the development of a multispectral Kerrison rongeur surgical instrument with an integrated optical sensor capable of detecting dura and nerve roots during spinal surgery. The goal of this award is to create the first Kerrison rongeur equipped with an...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), will support the development and clinical validation of an Optical Coherence Tomography (OCT) system and two specialized OCT imaging probes to enhance colorectal cancer screening. The $1,471,777 award to The General Hospital Corporation (doing business as Massachusetts General Hospital) aims to create an OCT system that can obtain 3D microscopic images of...
This Project Grant award of $686,000 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to develop an optimized, lead candidate tissue-adhesive endoscopic tattoo ink (TAT2) to overcome limitations of current commercial inks for marking gastrointestinal lesions. The new TAT2 ink is intended to demonstrate improved tissue retention, equivalent visual contrast, and reduced inflammatory potential...
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $1,250,000 in funding to Biodevek Inc., a Boston-based small business, to develop a novel sprayable hydrogel sealant for managing gastrointestinal (GI) lesions and bleeding. The project aims to create a minimally invasive, bio-adhesive hydrogel solution that can provide sustained lesion protection and hemostasis, potentially reducing...
This Project Grant award of $272,835 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program, supports the development and evaluation of a new Probe-Based Light Sheet Microscopy (PLSM) device for screening and diagnosis of anal cancer. The key objectives are to: 1) Develop the PLSM device, 2) Evaluate its clinical utility for in vivo imaging of...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $264,016 to Surgical Vision Systems, Inc. to design and develop a novel robotic surgery system for improving microvascular surgical procedures. The key objectives are to: 1) develop an optical coherence tomography imaging system integrated with a robotic microvascular suturing tool, 2) test the accuracy of the optical imaging for guiding needle placement in...

DYE-FREE, MULTIMODAL, QUANTITATIVE IMAGING TO ASSESS BOWEL PERFUSION DURING LAPAROSCOPIC COLORECTAL RESECTION - ANASTOMOTIC LEAK (AL) IS A SERIOUS COMPLICATION OF INTESTINAL SURGERY, WITH MANY POTENTIAL CAUSES. THIS COMPLICATION CARRIES WITH IT A REPORTED MORTALITY RANGING FROM 6 TO 39%. THE BEST TIME TO PREVENT A POSSIBLE AL IS DURING ITS CREATION IN THE OPERATING ROOM. A LEAK CAN OCCUR DUE TO A TECHNICAL ERROR, BUT FREQUENTLY IT OCCURS AS A CONSEQUENCE OF POORLY VASCULARIZED INTESTINE. CREATING A HEALTHY AND SAFE INTESTINAL ANASTOMOSIS REQUIRES A GOOD BLOOD SUPPLY TO THE TWO ENDS OF BOWEL TO BE JOINED. THE TOOLS FOR DIAGNOSING WELL-PERFUSED BOWEL INTRAOPERATIVELY ARE LIMITED AND OFTEN RELY ON THE SUBJECTIVE EVALUATION OF THE SURGEON. THIS IS PROBLEMATIC ESPECIALLY IN CIRCUMSTANCES IN WHICH THE BOWEL APPEARS TO BE "DUSKY" OR THREATENED BUT NOT CLEARLY NECROTIC. THE SURGEON CAN UTILIZE SEROSAL VISUALIZATION AND PALPATION OF THE MESENTERIC VESSELS, BUT THIS FAILS TO EVALUATE THE MICRO-PERFUSION OF THE INTESTINE ITSELF. IN ADDITION, MOST OF THE RESEARCH ON ADOPTION OF LAPAROSCOPIC TECHNIQUES IN COLORECTAL SURGERY SHOWS INCREASED RATES OF USE (55.4% OF THE TOTAL OF 309,816 PATIENTS WHO UNDERWENT ELECTIVE COLON RESECTION BETWEEN 2009 AND 2012 WERE PERFORMED MINIMALLY INVASIVELY). HOWEVER, TECHNIQUES USING LAPAROSCOPIC SURGERY OR MINIMALLY INVASIVE SURGERY (MIS) CAN BE EVEN LESS RELIABLE FOR DETERMINING BOWEL VIABILITY DUE TO LACK OF GROSS PALPATION. IN THIS RESEARCH, WE PROPOSE TO DEVELOP A DYE-FREE, MULTIMODAL LAPAROSCOPIC IMAGING SYSTEM FOR THE QUANTITATIVE ASSESSMENT OF BOWEL PERFUSION FOR PRECISE SURGICAL GUIDANCE DURING LAPAROSCOPIC (AND OPEN) INTESTINAL SURGERY. OPTOSURGICAL, LLC IS A SMALL BUSINESS THAT HAS ESTABLISHED A STRONG PARTNERSHIP WITH RESEARCHERS AT CHILDREN'S NATIONAL HOSPITAL, WHERE EXPERT CLINICIANS AND ENGINEERS WILL PROVIDE REQUISITE CLINICAL INSIGHT ON THE FULL DEVELOPMENT, PRECLINICAL VALIDATION, AND CLINICAL TRANSLATION OF THE PROPOSED TECHNOLOGY FROM THE BENCH TO THE OPERATING ROOM. THE GOAL OF THIS 1-YEAR RESEARCH PROPOSAL IS TO DEVELOP AND EVALUATE THE NOVEL MULTIMODAL IMAGING CAMERA SYSTEM FOR LAPAROSCOPIC ANASTOMOSIS THROUGH THE FOLLOWING SPECIFIC AIMS; AIM 1: TO PROTOTYPE THE MULTIMODAL CAMERA SYSTEM AND INTEGRATE THE SYSTEM INTO A COMMERCIALLY AVAILABLE LAPAROSCOPE; AIM 2: TO VALIDATE THE SYSTEM PRE-CLINICALLY IN A SWINE MODEL OF IN VIVO INTESTINAL ISCHEMIA (N=12). UPON SUCCESSFUL COMPLETION OF THIS STTR PHASE 1 PROJECT, WE WILL PROCEED WITH THE PHASE 2 STUDIES, WHEREIN WE WILL PREPARE A CLINICAL GRADE DEVICE AND EXECUTE ANIMAL STUDIES USING A SWINE MODEL WITH STATISTICAL VALIDATION, FOLLOWED BY A PILOT CLINICAL STUDY ON HUMAN SUBJECTS. THIS NEW OPTICAL IMAGING TECHNOLOGY HOLDS GREAT PROMISE FOR EVALUATING BOWEL PERFUSION AND POTENTIAL INTRINSIC INTESTINAL DISORDERS WITH THE GOAL OF REDUCING POSTOPERATIVE MORBIDITY/MORTALITY AND SECOND-LOOK OPERATIONS FOR SUSPECTED INTESTINAL LEAKS.

Posted 8/27/21, 12:00 AM